OSRH
OSR Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.12
+0.00%Next report
Analyst consensus
- Next report date
- Dec 2, 2026
- EPS estimate
- -$0.27
- Revenue estimate
- $780.0K
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$0.02
- EPS estimate
- -$0.28
- Revenue actual
- $315.7K
- Revenue estimate
- $780.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -435.4%
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 14, 2026 | -$0.28 | -$0.02 | Beat 92.86% | $315.7K |
| May 13, 2026 | -$0.29 | -$0.09 | Beat 68.97% | $484.1K |
| Mar 31, 2026 | -$0.10 | -$2.02 | Miss -1920.00% | $381.3K |
| Nov 12, 2025 | -$0.12 | -$0.10 | Beat 16.67% | $627.7K |
| Aug 14, 2025 | — | $0.02 | — | $1.1M |
| May 20, 2025 | — | -$1.04 | — | $761.3K |
| Nov 14, 2024 | — | -$0.06 | — | $849.8K |
| Aug 19, 2024 | — | -$0.02 | — | $831.7K |
| May 15, 2024 | — | -$0.60 | — | $910.2K |
| Aug 14, 2023 | — | $0.03 | — | — |
| May 22, 2023 | — | $0.01 | — | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 2, 2026